LISA: A web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 129, Issue 6, 2005, Pages 746-754

  Bury, Jonathan ^a,b   Hurt, Chris ^b,c   Roy, Anindita ^c   Cheesman, Louise ^c   Bradburn, Mike ^b   Cross, Simon ^a   Fox, John ^b   Saha, Vaskar ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acute lymphoblastic leukaemia; Chemotherapy; Childhood haematological malignancies; Clinical trials; Computing

Indexed keywords

MERCAPTOPURINE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; COMPUTER PROGRAM; DECISION SUPPORT SYSTEM; DRUG DOSE REGIMEN; INTERNET; INTERVIEW; MEDICATION ERROR; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE; STATISTICAL ANALYSIS;

ANTINEOPLASTIC AGENTS; CHILD; CLINICAL PROTOCOLS; CLINICAL TRIALS; CROSS-OVER STUDIES; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMPUTER-ASSISTED; GUIDELINE ADHERENCE; HUMANS; INTERNET; LEUKEMIA, LYMPHOCYTIC, ACUTE;

EID: 21344452785     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05541.x     Document Type: Article

References (33)

1. Agresti, A., Mehta, C.R. & Patel, N.R. (1990) Exact inference for contingency tables with ordered categories. Journal of the American Statistical Association, 85, 453-458.
2. Anon (1982) Duration of chemotherapy in childhood acute lymphoblastic leukaemia. The Medical Research Council's Working Party on Leukaemia in Childhood. Medical and Pediatric Oncology, 10, 511-520.
3. Aviziensis, A. & Chen, L. (1977) On the Implementation of N-version Programming for Software Fault Tolerance during Execution. Proceedings of IEEE COMPSAC 77, pp. 149-155.
4. Barnett, V. (1991) Sample Survey Principles and Methods. Edward Arnold, London, UK.
5. Baum, E., Sather, H., Nachman, J., Seinfeld, J., Krivit, W., Leikin, S., Miller, D., Joo, P. & Hammond, D. (1979) Relapse rates following cessation of chemotherapy during complete remission of acute lymphocytic leukemia. Medical and Pediatric Oncology, 7, 25-34.
6. Bezier, B. (1990) Software Testing Techniques. Van Nostrand and Reinhold, New York, USA.
7. Chessells, J.M., Durrant, J., Hardy, R.M. & Richards, S. (1986) Medical Research Council leukaemia trial - UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood. Journal of Clinical Oncology, 4, 1758-1764.
8. Chessells, J.M., Harrison, G., Lilleyman, J.S., Bailey, C.C. & Richards, S.M. (1997) Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia. British Journal of Haematology, 98, 945-951.
9. de Clercq, P.A., Blom, J.A., Korsten, H.H. & Hasman, A. (2004) Approaches for creating computer-interpretable guidelines that facilitate decision support. Artificial Intelligence in Medicine, 31, 1-27.
10. Dolan, G., Lilleyman, J.S. & Richards, S.M. (1989) Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council. Archives of Disease in Childhood, 64, 1231-1234.
11. Fox, J., Johns, N., Lyons, C., Rahmanzadeh, A., Thomson, R. & Wilson, P. (1997) PROforma: a general technology for clinical decision support systems. Computer Methods and Programs in Biomedicine, 54, 59-67.
12. Gaynon, P.S., Trigg, M.E., Heerema, N.A., Sensel, M.G., Sather, H.N., Hammond, G.D. & Bleyer, W.A. (2000) Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia, 14, 2223-2233.
13. Hann, I., Vora, A., Richards, S., Hill, F., Gibson, B., Lilleyman, J., Kinsey, S., Mitchell, C. & Eden, O.B. (2000) Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia. Leukemia, 14, 356-363.
14. Hann, I., Vora, A., Harrison, G., Harrison, C., Eden, O., Hill, F., Gibson, B. & Richards, S. (2001) Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. British Journal of Haematology, 113, 103-114.
15. Haward, R.A. (1995) Establishing cancer units. British Journal of Cancer, 72, 531-534.
16. Hurt, C., Fox, J., Bury, J. & Saha, V. (2003) Computerised advise in drug dosage decisions in childhood leukaemia: a method and a safety strategy. Lecture Notes in Artificial Intelligence, 2780, 158-162.
17. Kelly, M.A. & Oldham, J. (1997) The Internet and randomised controlled trials. International Journal of Medical Informatics, 47, 91-99.
18. Lallas, C.D., Preminger, G.M., Pearle, M.S., Leveillee, R.J., Lingeman, J.E., Schwope, J.P., Pietrow, P.K. & Auge, B.K. (2004) Internet based multi-institutional clinical research: a convenient and secure option. Journal of Urology, 171, 1880-1885.
19. Lennard, L., Welch, J.C. & Lilleyman, J.S. (1997) Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity. British Journal of Clinical Pharmacology, 44, 455-461.
20. Martin, J. & McClure, C.L. (1985) State transition diagrams. In: Diagramming Techniques for Analysts and Programmers, pp. 219-230. Prentice-Hall, New Jersey, USA.
21. Peeters, M., Koren, G., Jakubovicz, D. & Zipursky, A. (1988) Physician compliance and relapse rates of acute lymphoblastic leukemia in children. Clinical Pharmacology and Therapeutics, 43, 228-232.
22. Peleg, M., Tu, S., Bury, J., Ciccarese, P., Fox, J., Greenes, R.A., Hall, R., Johnson, P.D., Jones, N., Kumar, A., Miksch, S., Quaglini, S., Seyfang, A., Shortliffe, E.H. & Stefanelli, M. (2003) Comparing computer-interpretable guideline models: a case-study approach. Journal of the American Medical Informatics Association, 10, 52-68.
23. Pui, C.H., Sandlund, J.T., Pei, D., Campana, D., Rivera, G.K., Ribeiro, R.C., Rubnitz, J.E., Razzouk, B.I., Howard, S.C., Hudson, M.M., Cheng, C., Kun, L.E., Raimondi, S.C., Behm, F.G., Downing, J.R., Relling, M.V. & Evans, W.E. (2004) Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood, 104, 2690-2696.
24. Ramnarayan, P., Tomlinson, A., Rao, A., Coren, M., Winrow, A. & Britto, J. (2003) ISABEL: a web-based differential diagnostic aid for paediatrics: results from an initial performance evaluation. Archives of Disease in Childhood, 88, 408-413.
25. Relling, M.V., Hancock, M.L., Rivera, G.K., Sandlund, J.T., Ribeiro, R.C., Krynetski, E.Y., Pui, C.H. & Evans, W.E. (1999a) Mercaptopurine therapy intolerance and heterozygosity at the thiopurine 5-methyltransferase gene locus. Journal of the National Cancer Institute, 91, 2001-2008.
26. Relling, M.V., Hancock, M.L., Boyett, J.M., Pui, C.H. & Evans, W.E. (1999b) Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood, 93, 2817-2823.
27. Schmiegelow, K. (1991) Prognostic significance of methotrexate and 6-mercaptopurine dosage during maintenance chemotherapy for childhood acute lymphoblastic leukemia. Pediatric Hematology and Oncology, 8, 301-312.
28. Schmiegelow, K. & Pulczynska, M.K. (1990) Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts? American Journal of Pediatric Hematology/Oncology, 12, 462-467.
29. Schmiegelow, K., Pulczynska, M.K. & Seip, M. (1988) White cell count during maintenance chemotherapy for standard-risk childhood acute lymphoblastic leukemia: relation to relapse rate. Pediatric Hematology and Oncology, 5, 259-267.
30. Schmiegelow, K., Bjork, O., Glomstein, A., Gustafsson, G., Keiding, N., Kristinsson, J., Makipernaa, A., Rosthoj, S., Szumlanski, C., Sorensen, T.M. & Weinshilboum, R. (2003) Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 21, 1332-1339.
31. Schrappe, M., Reiter, A., Zimmermann, M., Harbott, J., Ludwig, W.D., Henze, G., Gadner, H., Odenwald, E. & Riehm, H. (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia, 14, 2205-2222.
32. Sutton, D.R. & Fox, J. (2003) The syntax and semantics of the PRO-forma guideline modeling language. Journal of the American Medical Informatics Association, 10, 433-443.
33. Vissers, M.C., Hasman, A. & der Linden, C.J. (1996) Impact of a protocol processing system (ProtoVIEW) on clinical behaviour of residents and treatment. International Journal of Biomedical Computing, 42, 143-150.